Mechanistically, the decreased expression of phosphorylated AKT and mTOR, as well as the increased levels of LC3 and cleaved caspase-3 observed in tumor tissues, mirror the molecular effects identified in IQ-treated ESCC cell lines. The gene discussed is CASP3; the disease is esophageal squamous cell carcinoma.